Starling Oncology, Inc. STLN
4.34 USD +0.34 (+8.50%)
At closeNov 11, 2026, 4:26 AM EST
4.68 +0.33 +7.72%
Pre-market · Nov 11, 4:26 AM ET
3.97 Day range 4.44
2.32 52-week range 7.13
- YTD
- +21.91%
- 1 year
- +31.12%
- Market cap
- 442.64M
- EPS (ttm)
- -0.28
- YTD return
- +21.91%
- 1-year return
- +31.12%
- Volume
- 6.36M
- Avg volume
- 1.75M
- Open
- 3.97
- Previous close
- 4.00
- Day's range
- 3.97 – 4.44
- 52-week range
- 2.32 – 7.13
5D -2.10 (-32.61%)
Financials — quick view
STLN Revenue — quarterly 169.77M
STLN Net income — quarterly -13.29M
STLN EPS — quarterly -0.13
News
Starling Oncology, Inc. (STLN) Q3 2026 Earnings Call Transcript 
B. Riley Securities Reiterates Buy on Starling Oncology, Lowers Price Target to $10 
Oncology Institute Q3 Earnings Call Highlights 
12 Health Care Stocks Moving In Friday's Pre-Market Session 
BTIG Maintains Buy on Starling Oncology, Raises Price Target to $10 
Starling Oncology, Inc. (STLN) Reports Q3 Loss, Beats Revenue Estimates 
Starling Oncology Q3 2026 Earnings Call Transcript - Starling Oncology Narrows FY2026 Sales Guidance from $650.000M-$670.000M to $650.000M-$660.000M vs $663.685M Est
Starling Oncology Q3 EPS $(0.13) Misses $(0.05) Estimate, Sales $169.767M Beat $169.047M Estimate 
Starling Oncology Reports Third Quarter 2026 Financial Results and Updates Full-Year 2026 Guidance
Your note
Sign in to keep a note on STLN — it syncs with the Stock Master app.